<DOC>
	<DOCNO>NCT00133770</DOCNO>
	<brief_summary>The aim study examine whether pantoprazole ( Protonix ) give continuous intravenous infusion 72 hour superior Protonix give day IV injection treatment erosive esophagitis .</brief_summary>
	<brief_title>Intravenous ( IV ) Pantoprazole Erosive Esophagitis</brief_title>
	<detailed_description>Gastroesophageal reflux disease ( GERD ) common disease affect 20-50 % adult Western Countries . The disease divide three clinical category : nonerosive reflux disease ( NERD ) , erosive reflux disease ( ERD ) , Barrett 's esophagus . Intravenous ( IV ) infusion produce fast steady acid suppression oral regimen . Furthermore , patient severe erosive esophagitis take pill mouth benefit IV formulation . Recently , observe heal severe erosive esophagitis continuous IV pantoprazole several patient 3 day . The safety IV pantoprazole demonstrate patient GERD , Zollinger-Ellison syndrome , bleed ulcer . This study define safety efficacy continuous IV pantoprazole treatment severe erosive esophagitis . Comparison : The continuous IV pantoprazole compare day IV pantoprazole 72 hour treatment severe erosive esophagitis .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Patients must men nonpregnant woman ( documented negative pregnancy test enrollment female child bear age ) least 18 year age Patients present severe erosive esophagitis confirm endoscopy ( baseline endoscopy within 24 hour study enrollment ) grade five six , without stricture and/or ulcer Patients legally authorize representative must capable understand give sign date informed consent study Patients high probability compliance completion study Patients le grade five esophagitis Patients esophagitis reflux esophagitis , infectious esophagitis esophageal cancer Patients present gastrointestinal bleeding , hematocrit decrease great 6 unit require 2 unit transfusion presentation time study Patients severe comorbidities , liver disease asparate transaminase ( AST ) alanine transaminase ( ALT ) great 3 time upper limit normal ( ULN ) ; alkaline phosphatase great 5 time ULN ; total bilirubin great 3.0 mg/dl ; kidney diseases serum creatinine great 2.0 mg/dl men 1.6 mg/dl woman ; heart diseases ; lung diseases ; sepsis ; airway intubation . Patients history glaucoma either eye ; history intraocular eye surgery within precede 3 month ; history , presence , sign optic nerve swell ; history acute change vision ; vision loss either eye . Patients malignancy ( except skin cancer ) require therapy within last 6 month Patients history allergy protonpump inhibitor ( PPI ) include pantoprazole Patients know human immunodeficiency virus infection Patients organ transplantation Patients without ability comply study protocol complete study judgment investigator Patients prior administration PPI ( within 72 hour ) histamine2 receptor antagonist ( within previous 24 hour ) study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>IV pantoprazole</keyword>
	<keyword>Esophagitis</keyword>
</DOC>